SoftMining

unleash the power of AI in drug discovery

SoftMining

Unleash the potential of AI in drug discovery

Our
Company

SoftMining is a company founded in 2019 that uses AI for the design of new drugs and new materials with unprecedented efficiency. The methods, models and algorithms developed during more than 15 years of university scientific research have been integrated into a complete development platform.

< 0
Years old
0
Products in the pipeline
0
Proprietary algorithms
0
Patents pending
€ 0 M
Funds raised
> 0

Scientific papers of the    scientific board

AI

Platform usable for drug discovery and biomaterials

Sysa

Multipurpose semantic engine

Our Science

We have developed new theoretical models (among others lipid membrane therapy, and semantic analysis of molecular dynamics trajectories) and new investigation techniques. These methods have made it possible to clarify the mechanism of action and to participate in the development of 3 antitumor molecules on clinical trials. In addition, two new molecules with antimicrobial activity have been developed and tested. These are two lead compounds for which tests on animal models and optimization have started.
Learn More
Our Pipelines

How we work

Click on the section of interest to learn more

DISEASE

Antimicrobials, anticancers and rare diseases

NETWORK

Analysis on complex protein network

EFFICACY

9 proprietary algorithms Multipurpose platform

SYNTHESIS

Robot assisted CRO services

RESULTS

4 patents pending 6 products

Our Team

Envelope
Linkedin
Skype
Stefano Piotto, PhD
CEO and Co-Founder

Stefano Piotto is Associate Professor at the University of Salerno, Department of Pharmacy where he teaches General Chemistry and Biomaterials. Master in Chemistry (cum laude) at the University of Rome, Italy. Ph.D. in Material Sciences at the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. He is the Director of the Bionam Research Center on Biomaterials at the University of Salerno, a center with more than 70 professors and researchers.

He is the creator of several algorithms used in computational biology and a method of semantic analysis.
Recurrent Visiting professor at University of Balearic Islands, Spain. In 2007 was co-founder of e-Solving Srl, a company active in e-learning and advanced visualization techniques in teaching science. In 2016 he was co-founder and CEO of SmartVase Srl, a startup active in the field of biomaterials.
Among several awards, in 2016 SmartVase receives the award “Premio dei Premi” as Best Innovative Company in Italy from the Italian President of Republic.

In 2019 he is co-founder and CEO of SoftMining Srl, a startup that combines Artificial Intelligence and Computational Drug Design.

Technical area

  • Head Drug design
  • Lucia Sessa
Envelope
Linkedin
  • Head AI and digital health
  • Luigi Di Biasi
Envelope
Linkedin
  • Head Biomaterials
Envelope
Linkedin

Non technical area

  • Head Marketing
  • TBA
  • Head Business development
  • Gennaro Tesone
Linkedin
  • Financials
  • Fabrizio Merola
Linkedin

International Board

  • Xavier Busquets
  • University of the Balearic Islands, Spain
  • Pablo Vicente Escribà
  • CEO Laminar Pharma
  • Laszlo Vigh
  • Hungarian Academy of Sciences; Biological Research Center, Hungary
  • Zsolt Török
  • Lipodom analytics kft, Hungary
Linkedin

Our partners

Laminar pharma
AWS
Expand
Digital Magic
Smart&Start Invitalia
Biovista
EIT Health
universitat de les Illes Balneares
ETH Zurich
University of Salerno

Our customers say

"Softmining has done an excellent work studying the physical-chemical parameters of the compound SJT4A, to its molecular targets both in precise predictive in silico models and with Surface Plasmon Resonance (SPR). The studies were carried out quickly and efficiently, as well as the technical reports, which were delivered with admirable speed"
Juan Carlos Ágreda
President of SJT Molecular Research S.L.

Our headquarter

Do you want to know us?

+39 089 969795

info (@) softmining.it